Neuralieve, maker of a portable, non-invasive device used to treat neurological problems, particularly migraines, has brought in $3.9 million of a targeted $7.5 million round of equity, according to a filing with the SEC. Based in Sunnyvale, Calif., the company includes a managing member of MedVenture Associates on its board of directors.
Post by